Global Autacoids and Related Drugs Market, By Route of Type (Amines- Histamines and 5-Hydroxytryptamine, Lipids-Prostaglandins and Peptide-Angiotensin), Drug Type (Lipid-Derived Autacoids, Polypeptide Autacoids, Endothelium-Derived Autacoids, and Biogenic Amines), Polypeptides (Vasopressin, Vasoactive Intestinal Polypeptide, Plasma Kinin), Decarboxylated Amino Acids (Serotonin and Histamine), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest Of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest Of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest Of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest Of Middle East And Africa) Industry Trends And Forecast To 2028
Market Analysis and Insights : Global Autacoids and Related Drugs Market
Global autacoids and related drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR of 3.80% in the above-mentioned research forecast period.
An autacoid is an organic substance; a hormone which is synthesized in one part of the organism and transported by blood or lymphatic system in another part of the organism, where it applies a physiologic effect. The types of available autacoids are amines histamines and 5-Hydroxytryptamine, lipids-prostaglandins and peptide-angiotensin. The pharmacological action of autacoids is observed in vital systems of the body. In Circulatory system, the arteries are constricted as well as widened by direct onset of 5-Hydroxytryptamine. In respiratory system, hyperventilation takes place. The 5- Hydroxytryptamine causes morphological changes in shape of platelets. The 5-Hydroxytryptamine agonists are therapeutically used as Fluoxetine, to curb depression and 5- Hydroxytryptamine antagonists are used as Dolasetron, for therapeutic indication of nausea. In the coming future, the systemic collaboration of autacoids in the autonomic nervous sytem can be used to study the response of cardiovascular system to radio-frequency in various frequency energy heating forms.
The rise in number of patients suffering from chronic diseases, rise in geriatric population, increased investment by Research and Development for autacoids as potential immunomodulators, production of novel drugs, increasing awareness about use of lipid autacoids for treatment of lipid metabolic disease are the key factors driving the market growth. However, the presence of stringent regulations by FDA for the drug approval, rise in product recalls, poor reimbursement framework, lack of awareness about the use of autacoids among the patient population are the restraints which can hamper the market growth. The presence of untapped opportunities , increase in number of upcoming healthcare infrastructure and testing centers and strategic initiatives by market players are the opportunities which are expected to boost the market growth. The challenges which are likely to tamper the market growth are the use of alternatives and the accessibility of off-label drug usage and strict supervisory maintenance for drug approval.
This autacoids and related drugs market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Autacoids and Related Drugs Market Scope and Market Size
The Autacoids and Related Drugs market is segmented on the basis of Route of type, drug type, polypeptides, decarboxylated amino acids, route of administration, and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of route of type, the autacoids and related drugs market is segmented into amines- histamines and 5-Hydroxytryptamine, lipids-prostaglandins and peptide-angiotensin.
- On the basis of drug type, the autacoids and related drugs market is segmented into lipid-derived autacoids, polypeptide autacoids, drugs related to endothelium-derived autacoids, and biogenic amines.
- On the basis of polypeptides, the autacoids and related drugs market is segmented into vasopressin, vasoactive intestinal polypeptide, plasma kinin.
- On the basis of decarboxylated amino acids, the autacoids and related drugs market is segmented into serotonin and histamine.
- On the basis of route of administration, the autacoids and related drugs market is segmented into oral and parenteral.
- On the basis of distribution channel, the autacoids and related drugs market has also been segmented into hospital pharmacies, retail pharmacies and online pharmacies.
Autacoids and Related Drugs Market Country Level Analysis
Autacoids and Related Drugs market is analyzed and market size information is provided by country, type, drug type, polypeptides, decarboxylated amino acids, route of administration, and distribution channel as referenced above.
The countries covered in the Autacoids and Related Drugs market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America is expected to hold the largest market share due to the increased count in number of local ailments, increased safety and implementation of drugs, rise in research and development initiatives. Asia-Pacific is expected to account for the fastest growing market due to rise in awareness about autacoids and other related drugs, strategic initiatives by market players, increased necessity for medical community to focus on the effects of chronic pain in patients.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Autacoids and Related Drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Autacoids and Related Drugs Market Share Analysis
Autacoids and Related Drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Autacoids and Related Drugs market.
The major players covered in the Autacoids and Related Drugs market are BEDFORD LABORATORIES, Bristol-Myers Squibb Company, APP Pharma, Abbott, Sanofi, CHATTEM, AstraZeneca, Hospira, among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-